Clinical trials

  • SEMAGLUTIDE for Type 2 diabetes | Diabetic retinopathy
  • OXYTOCIN SYNTHETIC for Autism spectrum disorder
  • GIREDESTRANT for Breast cancer (estrogen receptor–positive, HER2-negative, locally advanced or metastatic)
  • Carboplatin for Solid tumours with homologous recombination deficiency (HRD) / Fanconi anemia (FAD) DNA damage repair deficiency
  • APALUTAMIDE for Metastatic hormone-naïve prostate cancer | Metastatic hormone-sensitive prostate cancer
  • Pravastatin sodium for Hypercholesterolemia | Cardiovascular risk requiring primary or secondary prevention
  • MORPHINE SULFATE for Limb injuries | Traumatic pain
  • Dimethyl fumarate for Adrenomyeloneuropathy
  • sotorasib (AMG 510) for Advanced solid tumors | KRAS p.G12C mutation | Non-small cell lung cancer
  • LY3484356 for Breast cancer
  • SELPERCATINIB for Non-small cell lung cancer (RET fusion-positive)
  • MRNA-4157 for Non-small cell lung cancer | Resectable non-small cell lung cancer